New from AUGUSTUS: Apixaban-based dual therapy without aspirin works for AF with ACS
07 Oct 2019
bởiElvira Manzano
Treatment with apixaban and a P2Y12 inhibitor, but leaving off aspirin, may be an effective and safe option for patients with atrial fibrillation (AF) and acute coronary syndrome (ACS) regardless of presentation, a new analysis of the AUGUSTUS* trial has shown. However, questions remain on when to drop aspirin in patients with AF, requiring both dual antiplatelet therapy (DAPT) and anticoagulation.